Osteoarthritis (OA) is a debilitating, progressive disease of diarthrodial joints associated with aging. At the molecular level, OA is characterized by an imbalance between anabolic (i.e. extracellular matrix biosynthesis) and catabolic (i.e. extracellular matrix degradation) pathways in which articular cartilage is the principal site of tissue injury responses. The pathophysiology of OA also involves the synovium in that ‘nonclassical’ inflammatory synovial processes contribute to OA progression. Chondrocytes are critical to the OA process in that the progression of OA can be judged by the vitality of chondrocytes and their ability to resist apoptosis. Growth factors exemplified by insulin-like growth factor-1, its binding proteins and transforming growth factor-β contribute to anabolic pathways including compensatory biosynthesis of extracellular matrix proteins. Catabolic pathways are altered by cytokine genes such as interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α) which are upregulated in OA. In addition, IL-1 and TNF-α downregulate extracellular matrix protein biosynthesis while concomitantly upregulating matrix metalloproteinase (MMP) gene expression. When MMPs are activated, cartilage extracellular matrix degradation ensues apparently because levels of endogenous cartilage MMP inhibitors cannot regulate MMP activity. Therapeutic strategies designed to modulate the imbalance between anabolic and catabolic pathways in OA may include neutralizing cytokine activity or MMP gene expression or inhibiting signaling pathways which result in apoptosis dependent on mature caspase activity or mitogen-activated protein kinase (MAPK) activity. MAPK activity appears critical for regulating chondrocyte and synoviocyte apoptosis and MMP genes.

Keywords:
Chondrocytes, human, Apoptosis, Osteoarthritis, Cytokine, Signaling pathways
1.
Abbaszade, I., R.Q. Liu, F. Yang, S.A. Rosenfeld, O.H. Ross, J.R. Link, D.M. Ellis, M.D. Tortorella, M.A. Pratta, J.M. Hollis, R. Wynn, J.L. Duke, H. George, M.C. Hillman, Jr., K. Murphy, B.H. Wiswall, R.A. Copeland, C.P. Decicco, R. Bruckner, H. Nagase, Y. Itoh, R.C. Newton, R.L. Magolda, J.M. Trzaskos, G.F. Hollis, E.C. Arner, T.C. Burn (1999) Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 274: 23443–23450.
2.
Adams, C.S., W.E. Horton, Jr. (1998) Chondrocyte apoptosis increases with age in the articular cartilage of adult animals. Anat Rec 250: 418–425.
3.
Adams, J.M., S. Cory (1998) The Bcl-2 protein family: Arbiters of cell survival. Science 281: 1322–1325.
4.
Adcocks, C., P. Collin, D.J. Buttle (2002) Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage proteoglycan and type II collagen degradation in vitro. J Nutr 132: 341–346.
5.
Aigner, T., H.A. Kim (2002) Apoptosis and cellular viability. Issues in osteoarthritic cartilage degradation. Arthritis Rheum 46: 1986–1996.
6.
Aizawa, T., T. Kon, T.A. Einhorn, L.C. Gerstenfeld (2001) Induction of apoptosis in chondrocytes by tumor necrosis factor-alpha. J Orthop Res 19: 785–796.
7.
Alaaeddine, N., J.A. Di Battista, J.-P. Pelletier, J.-M. Cloutier, K. Kiansa, M. Dupuis, J. Martel-Pelletier (1997) Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation of TNF-alpha. J Rheumatol 24: 1985–1994.
8.
Angele, P., J.U. Yoo, C. Smith, J. Mansour, K.J. Jepsen, M. Nerlich B. Johnstone (2003) Cyclic hydrostatic pressure enhances chondrogenic phenotype of human mesenchymal cell differentiated in vitro. J Orthop Res, in press.
9.
Apte, S.S., M. Mattei, B.R. Olsen (1994) Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP-3 gene to chromosome 22. Genomics 19: 86–90.
10.
Ashkenazi, A., V. Dixit (1998) Death receptors: Signaling and modulation. Science 281: 1305–1308.
11.
Attur, M.G., M. Dave, M. Akamatsu, M. Ktaoh, A.R. Amin (2002a) Osteoarthritis or osteoarthrosis: The definition of inflammation becomes a semantic issue in the era of molecular medicine. Osteoarthritis Cartilage 10: 1–4.
12.
Attur, M.G., M.N. Dave, M.Y. Leung, C. Cipolletta, M. Meseck, S.L.C. Woo, A.R. Amin (2002b) Functional genomic analysis of type II IL-1β decoy receptor: Potential for gene therapy in human arthritis and inflammation. J Immunol 168: 2001–2010.
13.
Attur, M.G., R.N. Patel, S.B. Abramson, A.R. Amin (1997) Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum 140: 1050–1053.
14.
Banchereau, J., R.M. Steinman (1998) Dendritic cells and the control of immunity. Nature 392: 245–252.
15.
Barchowsky, A., D. Frieta, M.P. Vincenti (2000) Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: Divergence of IL-1 and TNF-dependent signal transduction of rabbit primary synovial fibroblasts. Cytokine 12: 1469–1479.
16.
Bee, Z., G.V. Crossingham, K.M. Clements, M.A. Adams, M. Sharif (2000) Chondrocyte death induced by cyclic compressive loading of articular cartilage: Evidence for involvement of apoptosis (abstract). Osteoarthritis Cartilage 8(suppl B): S53.
17.
Bigg, H.F., Y.E. Shi, Y.E. Lui, B. Steffenson, C.M. Overall (1997) Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2. J Biol Chem 272: 15496–15500.
18.
Blanco, F.J., R.L. Ochs, H. Schwarz, M. Lotz (1995) Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 146: 75–85.
19.
Bluteau, G., T. Conrozier, P. Mathieu, E. Vignon, D. Herbage F. Mallein-Gerin (2001) Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 1526: 147–158.
20.
Boldin, M.P., T.M. Goncharov, Y.V. Goltsev, D. Wallach (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/Apo-1 and TNF receptor-induced cell death. Cell 85: 803–815.
21.
Bresnihan, B. (2001) The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Semin Arthritis Rheum 30(suppl 2): 17–20.
22.
Buckbinder, L., R. Talbott, S. Valesco-Miguel, I. Takenaka, B. Faha, B.R. Seizinger, N. Kley (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646–649.
23.
Burns, T.F., W.S. El-Deiry (1999) The p53 pathway and apoptosis. J Cell Physiol 181: 231–239.
24.
Buttle, D., C.J. Handley, M.Z. Ilic, J. Saklatvala, J. Murata, A.J. Barrett (1993) Inhibition of proteoglycan release by a specific inhibitor of cathepsin B and an inhibitor of metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated degradation. Arthritis Rheum 36: 1709–1717.
25.
Chao, W., Y. Shen, L. Li, A. Rosenzweig (2002) Importance of FADD signaling in serum deprivation and hypoxia-induced cardiomyocyte apoptosis. J Biol Chem 277: 31639–31645.
26.
Chen, C.-T., N. Burton-Wurster, C. Borden, K. Hueffer, S.E. Bloom, G. Lust (2001a) Chondrocyte necrosis and apoptosis in impact damaged articular cartilage. J Orthop Res 19: 703–711.
27.
Chen, F., V. Castranova, X. Shi (2001b) New insights into the role of nuclear factor-κB in cell growth regulation. Am J Pathol 159: 387–397.
28.
Cheng, E.H.-Y., D.G. Kirsch, R.J. Clem, R. Ravi, M.B. Kastan, A. Bedl, K. Ueno, J.M. Hardwick (1997) Conversion of Bcl-2 to Bax-like death effector by caspases. Science 278: 1966–1968.
29.
Chinnaiyan, A.M., K. O’Rourke, M. Terwari, V.M. Dixit (1995) FADD, a novel death-domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505–512.
30.
Cleveland, J.L., J.N. Ihle (1995) Contenders in FasL/TNF death signaling. Cell 81: 479–482.
31.
Conus, S., T. Rosse, C. Borner (2000) Failure of Bcl-2 family members to interact with Apaf-1 in normal and apoptotic cells. Cell Death Differ 7: 947–954.
32.
Dahl, A.M., C. Klein, P.G. Andres, C.A. London, M.P. Lodge, R.C. Mulligan, A.K. Abbas (2000) Expression of bcl-X(L) restores cell survival, but not proliferation of effector differentiation, in CD28-deficient T lymphocytes. J Exp Med 191: 2031–2038.
33.
Deacon, K., J.L. Blank (1999) MEK-kinases directly activates MMK6 and MKK7 specific activators of the p38 and c-Jun-NH2-terminal kinases. J Biol Chem 274: 16604–16610.
34.
Denko, C.W., B. Boja (1993) Growth factors in asymptomatic osteoarthritis – Insulin, insulin-like growth factor-1, growth hormone. Inflammopharmacology 2: 71–76.
35.
Denko, C.W., B. Boja, C.J. Malemud (2003) Intra-erythrocyte deposition of growth hormone in rheumatic diseases. Rheumatol Int 23: 11–14.
36.
Denko, C.W., B. Boja, R.W. Moskowitz (1996) Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic diseases. Osteoarthritis Cartilage 4: 245–249.
37.
Denko, C.W., C.J. Malemud (1999) Metabolic disturbances and synovial joint responses in osteoarthritis. Front Biosci 4: d686–d693.
38.
D’Lima, D.D., S. Hashimoto, P.C. Chen, C.W. Colwell, Jr., M.K. Lotz (2001) Human chondrocyte apoptosis in response to mechanical injury. Osteoarthritis Cartilage 9: 712–719.
39.
Doré, S., J.-P. Pelletier, J.A. Di Battista, G. Tardif, P. Brazeau, J. Martel-Pelletier (1994) Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor-1 binding sites but are unresponsive to its stimulation. Arthritis Rheum 37: 253–263.
40.
Duckett, C.S. (2002) Apoptosis and NF-κB: The FADD connection. J Clin Invest 109: 579–580.
41.
Elkon, K.B. (1999) Caspases: Multifunctional proteases. J Exp Med 190: 1725–1727.
42.
Erlacher, L., R. Maier, R. Ullrich, H. Kiener, M. Aringer, M. Menschik, W. Graninger (1995) Differential expression of the protooncogene bcl-2 in normal and osteoarthritic human articular cartilage. J Rheumatol 22: 926–931.
43.
Evan, G., T. Littlewood (1998) A matter of life and death. Science 281: 1317–1321.
44.
Farrell, A.J., D.R. Blake, R.M. Palmer, S. Moncada (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51: 1219–1222.
45.
Feng, L., R. Balakir, P. Precht, W.E. Horton, Jr. (1999) Bcl-2 regulates chondrocyte morphology and aggrecan gene expression independent of caspase activation and full apoptosis. J Cell Biochem 74: 576–586.
46.
Feng, L., P. Precht, R.R. Balakir, W.E. Horton, Jr (1998) Evidence for a direct role of Bcl-2 in the regulation of articular chondrocyte apoptosis under conditions of serum withdrawal and retinoic acid treatment. J Cell Biochem 71: 303–309.
47.
Fisher, B.A., S. Mundle, A.A. Cole (2000) Tumor necrosis factor-alpha induced DNA cleavage in human articular chondrocytes may involve multiple endonucleolytic activities during apoptosis. Microsc Res Tech 50: 236–242.
48.
Freiss, D., J. Yoo, B. Johnstone (2002) MAP kinase signaling during in vitro chondrogenesis (abstract 0313). Trans Orthop Res Soc 27.
49.
French, A.S. (1992) Mechanotransduction. Annu Rev Physiol 54: 135–152.
50.
Frenkel, S.R., P.E. Di Cesare (1999) Degradation and repair of articular cartilage. Front Biosci 4: d671–d685.
51.
Ganu, V.S., S.-I. Hu, R. Melton, C. Winter, V.M. Goldberg, T.M. Haqqi, C.J. Malemud (1994) Biochemical and molecular characterization of stromelysin synthesized by human osteoarthritic chondrocytes in culture stimulated with recombinant interleukin-1. Clin Exp Rheumatol 12: 489–496.
52.
Gao, G., J. Westling, V.P. Thompson, T.D. Howell, P.E. Gottschall, J.D. Sandy (2002) Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal trunction. J Biol Chem 277: 11034–11041.
53.
Gearing, A.J., P. Beckett, M. Christidoulous, M. Churchill, J. Clements, A.H. Davidson, A.H. Drummond, W.A. Galloway, R. Gilbet, J.L. Gordon, T.M. Leber, M. Manigan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L.M. Wood, K. Woolley (1994) Processing of tumor necrosis factor-alpha precursor by metalloproteinases. Nature 370: 555–557.
54.
Gebstein, A., S. Shapiro, N. Lahat, E. Livne (2002) Matrix metalloproteinase activity and mRNA expression in cartilage of temporomandibular and knee joints in growth development and aging (abstract). Bone 30(suppl): 27S.
55.
Geng, Y., J. Valbracht, M. Lotz (1996) Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. J Clin Invest 98: 2292–2299.
56.
Goldring, M.B. (1999) The role of cytokines as inflammatory mediators in osteoarthritis: Lessons from animal models. Connect Tissue Res 40: 1–11.
57.
Gouze, J.N., A. Bianchi, P. Bécuwe, M, Dauça, P. Netter, J. Magdalou, B. Terlain, K. Bordji (2002) Glucosamine modulates IL-1 induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-κB pathway. FEBS Lett 510: 166–170.
58.
Grabowski, P.S., P.K. Wright, R.J. Van’t Hof, M.F. Helfrich, H. Ohshima, S.H. Ralston (1997) Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid and osteoarthritis. Br J Rheumatol 36: 651–655.
59.
Green, D.R., J.C. Reed (1998) Mitochondria and apoptosis. Science 281: 1309–1312.
60.
Gunther, M., H.D. Haubeck, E. van der Leur, J. Blaser, S. Bender, I. Gutgemann, D.C. Fischer, H. Tschesche, H. Greiling, P.C. Heinrich, L. Graeve (1994) TGF-β1 regulates tissue inhibitor of metalloproteases-1 expression in differentiated human articular chondrocytes. Arthritis Rheum 37: 395–405.
61.
Gupta, S. (2002) A decision between life and death during TNF-α signaling. J Clin Immunol 22: 185–194.
62.
Han, Z., D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, A.M. Manning, G.S. Firestein (2001b) c-Jun-N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108: 73–81.
63.
Han, Z., L. Chang, Y. Yamanishi, M. Karin, G.S. Firestein (2001a) Joint damage and inflammation in c-Jun-N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. Arthritis Rheum 46: 818–823.
64.
Haqqi, T.M., D.D. Anthony, S. Gupta, N. Ahmed, M.-S. Lee, G.K. Kumar, H. Mukhtar (1999) Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci USA 96: 4524–4529.
65.
Haqqi, T.M., D.D. Anthony, C.J. Malemud (2000) Chondrocytes; in Tsokos, G.C. (ed): Current Molecular Medicine: Principles of Molecular Rheumatology. Totowa, Humana Press, pp 267–277.
66.
Hashimoto, S., R.L. Ochs, S. Komiya, M. Lotz (1998) Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum 41: 1632–1638.
67.
Hashimoto, S., K. Takahashi, D. Amiel, R.D. Coutts, M. Lotz (1997) Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum 40: 1749–1755.
68.
Hembry, R.M., M.R. Bagga, J.J. Reynolds, D.L. Hamblen (1995) Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 54: 25–32.
69.
Héraud, F., A. Héraud, M.-F. Harmand (2000) Apoptosis in normal and osteoarthritic human articular cartilage. Ann Rheum Dis 59: 959–965.
70.
Homandberg, G.A. (1999) Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments. Front Biosci 4: d713–d730.
71.
Hsu, S.C., M.A. Gavrilin, H.H. Kee, C.C. Wu, S.H. Han, M.Z. Lai (1998) NF-κB-dependent Fas ligand expression. Eur J Immunol 29: 2948–2956.
72.
Huang, W., W.Q. Li, F. Dehnade, M. Zafarullah (2002) Tissue inhibitor of metalloproteinase-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J Cell Biochem 85: 295–303.
73.
Hui, W., A.D. Rowan, T. Cawston (2001) Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-β1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-α. Cytokine 16: 31–35.
74.
Iozzo, R.V., A.D. Murdoch (1996) Proteoglycans of the extracellular environment: Clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 10: 598–614.
75.
Isaksson, O.G.P., A. Lindahl, A. Nilsson, J. Isgaard (1987) Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8: 426–438.
76.
Islam, N., T.M. Haqqi, K.J. Jepsen, M. Kraay, J.F. Welter, V.M. Goldberg, C.J. Malemud (2002) Hydrostatic pressure induces apoptosis in human chondrocytes from osteoarthritic cartilage through up-regulation of tumor necrosis factor-α, inducible nitric oxide synthase, p53, c-myc and bax-α and suppression of bcl-2. J Cell Biochem 87: 266–178.
77.
Islam, S., N. Islam, T. Kermode, B. Johnstone, H. Mukhar, R.W. Moskowitz, V.M. Goldberg, C.J. Malemud, T.M. Haqqi (2000) Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun 270: 793–797.
78.
Islam, S., T. Kermode, D. Sultana, R.W. Moskowitz, H. Mukhtar, C.J. Malemud, V.M. Goldberg, T.M. Haqqi (2001) Expression profile of protein kinase genes in human osteoarthritis chondrocytes. Osteoarthritis Cartilage 9: 684–693.
79.
Jiang, Y., H.K. Genant, I. Watt, M. Cobby, B. Bresnihan, R. Aitchison, D. McCabe (2000) A multicenter, double-blind dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 43: 1001–1009.
80.
Juo, P., M.S. Woo, C.J. Kuo, P. Signorelli, H.P. Biemann, Y.A. Hannun, J. Blenis (1999) FADD is required for multiple signaling events downstream of the receptor Fas. Cell Growth Differ 10: 797–804.
81.
Kacena, M., G.A. Merrel, S. Konda, K.M. Wilson, Y. Xi, M.C. Horowitz (2001) Inflammation and bony changes at the temporomandibular joint. Cells Tissues Organs 169: 257–264.
82.
Kavanagh, E., M. Abiri, Y.S. Bland, D.E. Ashhurst (2002) Division and death of cells in developing synovial joints and long bones. Cell Biol Int 26: 679–688.
83.
Kelly, M., C.M. Geigerman, G. Loo (2001) Epigallocatechin gallate protects U937 cell against nitric-oxide induced cell cycle arrest and apoptosis. J Cell Biochem 81: 647–658.
84.
Kim, S.-J., J.-W. Ju, C.-D. Oh, Y.-M. Yoon, W.K. Song, J.-H. Kim, Y.J. Yoo, O.-S. Bang, S.-S. Kang, J.-S. Chun (2002) ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3 and differentiation status. J Biol Chem 277: 1332–1339.
85.
Kim, H.A., Y.J. Lee, S.C. Seong, K.W. Choe, Y.W. Song (2002) Apoptotic chondrocyte death in human osteoarthritis. J Rheumatol 27: 455–462.
86.
Kluck, R.M., E. Bossy Wetzel, D.R. Green, D.D. Newmeyer (1997) The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275: 1132–1136.
87.
Ko, K.S., C.A.G. McCulloch (2001) Intracellular mechanotransduction: Cellular circuits that coordinate tissue responses to mechanical loading. Biochem Biophys Res Commun 285: 1077–1083.
88.
Kobayashi, K., H. Mishima, S. Hashimoto, R.S. Goomer, F.L. Harwood, M. Lotz, H. Moriya, D. Amiel (2001) Chondrocyte apoptosis and regional expression of nitric oxide in the medical meniscus following partial meniscectomy. J Orthop Res 19: 802–808.
89.
Kobayashi, T., K. Okamoto, T. Kobata, T. Hasunuma, T. Kato, H. Hamada, K. Nishioka (2000) Novel gene therapy for rheumatoid arthritis by FADD gene transfer: Induction of apoptosis of rheumatoid synoviocytes but not chondrocytes. Gene Ther 7: 527–533.
90.
Kühn, K., S. Hashimoto, M. Lotz (2000) IL-1β protects human chondrocytes from CD-95-induced apoptosis. J Immunol 164: 2233–2239.
91.
Kühn, K., M. Lotz (2001) Regulation of CD95 (Fas/APO-1)-induced apoptosis in human chondrocytes. Arthritis Rheum 44: 1644–1653.
92.
Kuno, K., Y. Okada, H. Kawashima, H. Nakamura, M. Miyasaka, H. Ohno, K. Matsushima (2000) ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 478: 241–245.
93.
Levine, A. (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323–331.
94.
Li, P., D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, E.S. Alnemri, X. Wang (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase 9 complex initiates an apoptotic protease cascade. Cell 91: 479–489.
95.
Liacini, A., J. Sylvester, W.Q. Li, M. Zafarullah (2002) Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-κB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 21: 251–262.
96.
Lin, H., H.-M. Zhang, C. Chen, B.D. Chen (2000) Apoptosis of Mo7e leukemia cells is associated with the cleavage of Bcl-2 into a shortened fragment that is not functional for heterodimerization with Bcl-2 and Bax. Exp Cell Res 261: 180–186.
97.
Lipsky, P.E., D.M. van der Heijde, E.W. St. Clair, D.E. Furst, F.C. Breedveld, J.R. Kalden, J.S. Smolen, M. Weisman, P. Emery, M. Feldmann, G.R. Harriman, R.N. Maini (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343: 1594–1602.
98.
Loesser, R.F., G. Shanker (2000) Autocrine stimulation by insulin-like growth factor 1 and insulin-like growth factor 2 mediates chondrocyte survival in vitro. Arthritis Rheum 43: 1552–1559.
99.
Malemud, C.J. (1999) Fundamental pathways in osteoarthritis: An overview. Front Biosci 4: d659–d661.
100.
Malemud, C.J., V.M. Goldberg, L.M. Miller (1987) Synthesis of a ‘free’ form of hyaluronic acid by articular chondrocytes in monolayer culture. Biochem Int 14: 987–995.
101.
Malemud, C.J., T.M. Haqqi, K.J. Jepsen, N. Islam, M. Kraay, J.Welter, V.M. Goldberg (2001) Induction of apoptosis in human chondrocytes by hydrostatic pressure (abstract). Osteoarthritis Cartilage 9(suppl B): S8.
102.
Malemud, C.J., W. Killeen, T.M. Hering, A.F. Purchio (1991) Enhanced sulfated-proteoglycan core protein synthesis by incubation of rabbit chondrocytes with recombinant TGF-β1. J Cell Physiol 149: 152–159.
103.
Malfait, A.-M., R.-Q. Liu, K, Ijiri, S. Komiya, M.D. Tortorella (2002) Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 277: 22201–22208.
104.
Martel-Pelletier, J., N. Alaaeddine, J.-P. Pelletier (1999b) Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci 4: d694–d703.
105.
Martel-Pelletier, J., J.-M. Cloutier, J.-P. Pelletier (1990) Cathepsin B and cysteine protease inhibitors in human OA: Effect of intra-articular steroid injections. J Orthop Res 8: 336–344.
106.
Martel-Pelletier, J., J. Di Battista, D. Lajeunesse (1999a) Biochemical factors in joint articular tissue degradation in osteoarthritis; in Reginster, J.-Y., J.-P. Pelletier, J. Martel-Pelletier, Y. Henrontin (eds): Osteoarthritis – Clinical and Experimental Aspects. Berlin, Springer, pp 156–187.
107.
Martel-Pelletier, J., M.P. Faure, R. McCollum, F. Mineau, J.-M. Cloutier, J.-P. Pelletier (1991a) Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage. J Rheumatol 18: 1863–1871.
108.
Martel-Pelletier, J., R. McCollum, N. Fujimoto, K. Obata, J.-M. Cloutier, J.-P. Pelletier (1994) Excess of metalloproteinases over tissue inhibitor of metalloproteinase may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 70: 807–815.
109.
Martel-Pelletier, J., J.-P. Pelletier, C.J. Malemud (1988) Activation of neutral metalloproteases in human osteoarthritic knee cartilage: Evidence for degradation in the core protein of sulphated proteoglycan. Ann Rheum Dis 47: 801–808.
110.
Martel-Pelletier, J., M. Zafarullah, S. Kodama, J.-P. Pelletier (1991b) In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage. J Rheumatol 18(suppl 27): 80–84.
111.
Martin, J.A., S.M. Ellerbrook, J. Buckwalter (1997) Age-related decline in chondrocyte response to insulin-like growth factor-I: The role of growth factor binding proteins. J Orthop Res 15: 491–498.
112.
Matsui, K., A. Fine, B. Zhu, A. Marshak-Rothstein, S.T. Ju (1998) Identification of two NF-κB sites in CD95 ligand (Fas ligand) promoter: Functional analysis in T cell hybridoma. J Immunol 161: 3469–3473.
113.
McInnes, I.B, B.P. Leung, M. Field, X.Q. Wei, F.P. Huang, R.D. Sturrock, A. Kinninmonth, J. Weidner, R. Mumford, F.Y. Liew (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184: 1519–1524.
114.
Mehraban, F., M.H. Tindal, M.M. Proffitt, R.W. Moskowitz (1997) Temporal pattern of cysteine endopeptidase (cathepsin B) expression in cartilage and synovium from experimental osteoarthritis rabbit knees: Gene expression in chondrocytes in response to interleukin-1 and matrix depletion. Ann Rheum Dis 56: 108–115.
115.
Mengshol, J.A., M.P. Vincenti, C.I. Coon, A. Barchowsky, C.E. Brinckerhoff (2000) Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase and nuclear factor kappaB: Differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 43: 801–811.
116.
Messai, H., Y. Duchossoy, A.-M. Khatib, A. Panasyuk, D.R. Mitrovic (2000) Articular chondrocytes from aging rats respond poorly to insulin-like growth factor-1: An altered signaling pathway. Mech Ageing Dev 115: 21–37.
117.
Middleton, J., A. Manthey, J. Tyler (1996) Insulin-like growth factor (IGF) receptor, IGF-I, interleukin-1β (IL-1β), and IL-6 mRNA expression in osteoarthritic and normal human cartilage. J Histochem Cytochem 44: 133–141.
118.
Middleton, J.F.S., J.A. Tyler (1992) Upregulation of insulin-like growth factor I gene expression in lesions of osteoarthritic human articular cartilage. Ann Rheum Dis 51: 440–447.
119.
Mohtai, M., R.L. Smith, D.J. Schurman, Y. Tsuji, F.M. Torti, N.I. Hutchinson, G. Stetler-Stevenson, G.I. Goldberg (1993) Expression of a 92-kDa type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin-1. J Clin Invest 92: 179–185.
120.
Morales, T.I. (1995) The role of signaling factors in articular cartilage homeostasis and osteoarthritis; in Kuettner, K.E., V.M. Goldberg (eds): Osteoarthritic Disorders. Rosemont, American Academy of Orthopaedic Surgeons, pp 261–270.
121.
Murrell, G.A.C., D. Jang, R.J. Williams (1995) Nitric oxide activated metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 206: 15–21.
122.
Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O’Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, M. Mann, P.H. Krammer, M.E. Peter, V.M. Dixit (1996) FLICE, a novel FADD-homologous ICE/ced-3-like protease, is recruited to the CD95 (Fas/apo-1) death-inducing signaling complex. Cell 85: 817–825.
123.
Nicholson, D.W. (2001) Apoptosis. Baiting death inhibitors. Nature 410: 33–34.
124.
Ninomiya-Tsugi, J., K. Kashimoto, A. Hiyama, J.-I. Inoue, Z. Cao, K. Matsumoto (1999) The kinase TAK1 can activate NIK-IκB as well as MAP kinase cascade in the IL-1 signalling pathway. Nature 398: 252–256.
125.
Notoya, K., D.G. Jovanovic, P. Raboul, J. Martel-Pelletier, F. Mineau, J.-P. Pelletier (2000) The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol 165: 3402–3410.
126.
Nuttall, M.E. (2001) Drug discovery and target validation. Cells Tissues Organs 169: 265–271.
127.
O’Connor, L., A. Strasser (1999) The Bcl-2 protein family; in Kumar, S. (ed): Apoptosis: Biology and Mechanisms. Heidelberg, Springer, pp 173–207.
128.
Okada, Y., M. Shinmei, O. Tanaka, K. Naka, A. Kimura, I. Nakanishi, M. Bayliss, K. Iwata, H. Nagase (1992) Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66: 680–690.
129.
Pelletier, J.-P., J. Martel-Pelletier, S.B. Abramson (2001) Osteoarthritis, an inflammatory disease. Potential implication for the selection of new therapeutic targets. Arthritis Rheum 44: 1237–1247.
130.
Pelletier, J.-P., R. McCollum, J.-M. Cloutier, J. Martel-Pelletier (1995) Synthesis of metalloproteases and interleukin-6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol 22: 109–114.
131.
Pelletier, J.-P., F. Mineau, M.P. Faure, J. Martel-Pelletier (1990) Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum 33: 1466–1476.
132.
Petterson, I., Y. Figenshau, E. Olsen, W. Bakkelund, B. Smedsröd, B. Sveinbjörnsson (2002) Tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in human articular chondrocytes in vitro. Biochem Biophys Res Commun 296: 671–676.
133.
Polyak, K., Y. Xia, J.L. Zweier, K.W. Kinzler, B. Vogelstein (1997) A model for p53-induced apoptosis. Nature 389: 300–305.
134.
Poole, A.R. (1999) An introduction to the pathophysiology of osteoarthritis. Front Biosci 4: d662–d670.
135.
Prisco, M., A. Hongo, M.G. Rizzo, A. Sacchi, R. Baserga (1997) The insulin-like growth factor I receptor is a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol Cell Biol 17: 1084–1092.
136.
Puzas, J.E., J.-M. Landreau, R. Tallents, J. Albright, E.D. Schwarz, R. Landesberg (2001) Degradative pathways in tissues of the temporomandibular joint. Cells Tissues Organs 169: 248–256.
137.
Reed, J.C. (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1–6.
138.
Reed, J.C. (1997) Cytochrome c: Can’t live with it; can’t live without it. Cell 91: 559–562.
139.
Reed, J.C. (2000) Mechanisms of apoptosis. Am J Pathol 157: 1415–1430.
140.
Sachs, B.L., V.M. Goldberg, L. Getzy, R.W. Moskowitz, C.J. Malemud (1982) A histopathologic differentiation of tissue types in human osteoarthritic cartilage. J Rheumatol 9: 210–216.
141.
Saeed Sheikh, M., A.J. Fornace, Jr. (2000) Role of p53 family members in apoptosis. J Cell Physiol 182: 171–181.
142.
Salvesen, G.S., V.M. Dixit (1997) Caspase activation: The induced-proximity model. Proc Natl Acad Sci USA 96: 10964–10967.
143.
Sandell, L.J. (1995a) Molecular biology of collagens in normal and osteoarthritic cartilage; in Kuettner, K.E., V.M. Goldberg (eds): Osteoarthritic Disorders. Rosemont, American Academy of Orthopaedic Surgeons, pp 131–146.
144.
Sandell, L.J., H. Chansky, O. Zamparo, T.M. Hering (1995b) Molecular biology of cartilage proteoglycans and link protein; in Kuettner, K.E., V.M. Goldberg (eds): Osteoarthritic Disorders. Rosemont, American Academy of Orthopaedic Surgeons, pp 117–130.
145.
Sandy, J.D., C.R. Flannery, P.J. Neame, L.S. Lohmander (1992) The structure of aggrecan fragments in human synovial fluid: Evidence for involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 89: 1512–1516.
146.
Sandy, J.D., J. Westling, R.D. Kenagy, M.L. Iruela-Arispe, C. Verscharen, J.C. Rodriguez-Mazaneque, D. Zimmermann, J.M. Lemire, J.W. Fischer, T.N. Wight, A.W. Clowes (2001) Versican V1 proteolysis in human aorta in vivo occurs at Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 276: 13372–13378.
147.
Shakibaei, M., G. Schulze-Tanzil, P. de Souza, T. John, M. Rahmanzadeh, R. Rahmanzadeh, H.-J. Merker (2001) Inhibition of mitogen-activated protein kinase induces apoptosis of human chondrocytes. J Biol Chem 276: 13289–13294.
148.
Singh, R., S. Ahmed, N. Islam, V.M. Goldberg, T.M. Haqqi (2002) Epigallocatechin-3-gallate inhibits interleukin-1β-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes. Suppression of nuclear factor κB activation by degradation of the inhibitor of nuclear factor κB. Arthritis Rheum 46: 2079–2086.
149.
Singh, R., S. Ahmed, T. Kermode, C.J. Malemud, R.W. Moskowitz, T.M. Haqqi (2001) Epigallocatechin-3-gallate (EGCG) inhibits interleukin-1β-induced activation of mitogen-activated protein kinases (p-38MAPK, JNK/SAPK), nuclear factor-κB (NF-κB), expression of nitric oxide synthase, production of nitric oxide and IL-6 in human osteoarthritis chondrocytes (abstract). Osteoarthritis Cartilage 9(suppl): S40.
150.
Singh, R., S. Ahmed, C.J. Malemud, V.M. Goldberg, T.M. Haqqi (2003) Epigallocatechin-3-gallate selectively inhibits interleukin-1β-induced expression of mitogen activated protein kianse subgroup c-Jun-N-terminal kinase in human osteoarthritis chondrocytes. J Orthop Res 21: 102–107.
151.
Sirum, K.L., C.E. Brinckerhoff (1989) Cloning of the genes for human stromelysin and stromelysin 2: Differential expression in rheumatoid synovial fibroblasts. Biochemistry 28: 8691–8698.
152.
Smaili, S.S., Y.T. Hsu, K.M. Sanders, J.T. Russell, R.L. Roule (2001) Bax translocation to mitochondria subsequent to rapid loss of mitochondrial membrane potential. Cell Death Differ 8: 909–920.
153.
Smith, R.L. (1999) Degradative enzymes in osteoarthritis. Front Biosci 4: d704–d712.
154.
Sun, Y., J.M. Cheung, J. Martel-Pelletier, J.P. Pelletier, L. Wenger, R.D. Altman, D.S. Howell, H.S. Cheung (2000a) Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13). J Biol Chem 275: 11327–11332.
155.
Sun, X., L. Wie, C.M. Davis, Q. Chen (2002) Anti-fas induction of apoptosis in human osteoarthritic chondrocytes through activating transcription factor 2 and caspase-3: Dependence on p38 mitogen-activated protein kinase (abstract 0195). Trans Orthop Res Soc 27.
156.
Sun, B.H., X.P. Zhao, B.J. Wang, D.L. Yang, L.J. Hao (2000b) FADD and TRADD expression and apoptosis in primary hepatocellular carcinoma World J Gastroenterol 6:223–227.
157.
Susin, S.A., N. Zamzami, M. Castedo, E. Daugas, H.G. Wang, S. Geley, F. Fassy, J.C. Reed, G. Kroemer (1997) The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas, APO-1/CD95- and ceramide-induced apoptosis. J Exp Med 186: 25–37.
158.
Tanaka, M., M.E. Fuentes, K. Yamaguchi, M.H. Durnin, S.A. Dalrymple, K.L. Hardy, D.V. Goeddel (1999) Embryonic lethality, liver degeneration and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10: 421–429.
159.
Thonar, E.J.-M.A., K. Matsuda, D.H. Manicourt, K.E. Kuettner (1999) Structure and function of normal human articular cartilage; in Reginster, J.-Y., J.-P. Pelletier, J. Martel-Pelletier, Y. Henrontin (eds): Osteoarthritis – Clinical and Experimental Aspects. Berlin, Springer, pp 1–19.
160.
Thornberry, N.A., Y. Lazebnik (1998) Caspases: Enemies within. Science 281: 1312–1316.
161.
Tomicic, M.T., B. Kaina (2000) Hamster bcl-2 protein is cleaved in vitro and in cells by caspase-9 and caspase-3. Biochem Biophys Res Commun 281: 404–408.
162.
Tortorella, M.D., T.C. Burn, M.A. Pratta, I. Abbaszade, J.M. Hollis, R. Liu, S.A. Rosenfeld, R.A. Copeland, C.P. Decicco, R. Wynn, A. Rockwell, F. Yang, J.L. Duke, K. Solomon, H. George, R. Bruckner, H. Nagase, Y. Itoh, D.M. Ellis, H. Ross, B.H. Wiswall, K. Murphy, M.C. Hillman, Jr., G.F. Hollis, R.C. Newton, R.L. Magolda, J.M. Trzaskos, E.C. Arner (1999) Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins. Science 284: 1664–1666.
163.
Urayama, S., A. Kawakami, T. Nakashima, S. Yamasaki, A. Hida, H. Ida, M. Kamamichi, H. Nakamura, T. Origuchi, K. Migita, Y. Kawabe, K. Eguchi (2001) New disease-modifying antirheumatic drug 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298) selectively augments activation-induced T cell death. J Lab Clin Med 138: 11–17.
164.
Van den Berg, W.B., P.M. van der Kraan, H.M. van Beuningen (1999) Role of growth factors and cartilage repair; in Reginster, J.-Y., J.-P. Pelletier, J. Martel-Pelletier, Y. Henrontin (eds): Osteoarthritis – Clinical and Experimental Aspects. Heidelberg, Springer, pp 188–209.
165.
Verhagen, A.M., D.L. Vaux (1999) Molecular mechanisms in apoptosis; an overview; in Kumar, S. (ed): Apoptosis: Biology and Mechanisms. Berlin, Springer, pp 11–24.
166.
Vincenti, M.P., C.E. Brinckerhoff (2001) The potential of signal transduction inhibitors for the treatment of arthritis: Is it all just JNK? J Clin Invest 108: 181–183.
167.
Vuolteenaho, K., T. Moilanen, M. Hämäläinen, E. Moilanen (2002) Effects of TNF-α antagonists on nitric oxide production in human cartilage. Osteoarthritis Cartilage 10: 327–332.
168.
Webb, G.R., C.I. Westacott, C.J. Elson (1997) Cartilage tumor necrosis factor alpha receptors and focal loss of cartilage in osteoarthritis. Osteoarthritis Cartilage 5: 427–437.
169.
Webb, G.R., C.I. Westacott, C.J. Elson (1998) Osteoarthritic synovial fluid and synovium supernatants up-regulate tumor necrosis factor receptors on human articular chondrocytes. Osteoarthritis Cartilage 6: 167–176.
170.
Westacott, C.I., R.M. Atkins, P.A. Dieppe, C.J. Elson (1994) Tumor necrosis factor-alpha receptor expression on chondrocytes isolated from human articular cartilage. J Rheumatol 21: 1710–1715.
171.
Westacott, C.I., A.F. Baraket, L. Wood, M.J. Perry, P. Nelson, I. Bisbinas, L. Armstrong, A.B. Miller, C.J. Elson (2000) Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis. Osteoarthritis Cartilage 8: 213–221.
172.
Wolter, K.G., Y.-T. Hsu, C.L. Smith, A. Nechushtan, X.-G. Xi, R.J. Youle (1997) Movement of Bax from cytosol to mitochondria during apoptosis. J Cell Biol 139: 1281–1292.
173.
Wright, J.K., T.E. Cawston, B.I. Hazleman (1991) TGF-β stimulates the production of tissue inhibitor of metalloproteases (TIMP) by human synovium and skin fibroblasts. Biochim Biophys Acta 1094: 207–210.
174.
Xerri, L., E. Devilard, R. Bouabdallah, A.-M. Stoppa, J. Hassoun (1999) FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis. Br J Haematol 106: 652–661.
175.
Yang, Y.L., X.M. Li (2000) The IAP family: Endogenous caspase inhibitors with multiple biological activities. Cell Res 10: 169–177.
176.
Yang, J., Y. Lin, Z. Guo, J. Cheng, J. Huang, L. Deng, W. Liao, Z. Chen, Z.-G. Liu, B. Su (2000) The essential role of MEKK3 in TNF-induced NF-κB activation. Nat Immunol 2: 620–624.
177.
Yang, J., X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.-I. Peng, D.P. Jones, X. Wang (1997) Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275: 1129–1132.
178.
Yang, R., Z. Yan, F. Chen, G.K. Hansson, R. Kiessling (2002) Hyaluronic acid and chondroitin sulfate A rapidly promote differentiation of immature DC with upregulation of costimulatory and antigen-presenting molecules and enhancement of NF-κB and protein kinase activity. Scand J Immunol 55: 2–13.
179.
Yin, X.-M., Z.N. Oltval, S.J. Korsmeyer (1994) BH1 and BH2 domains are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321–323.
180.
Zafarullah, M., J. Su, J. Martel-Pelletier, J.A. Di Battista, B.G. Costello, W.G. Stetler-Stevenson, J.-P. Pelletier (1996) Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA is constitutively expressed in bovine, human normal and osteoarthritic articular chondrocytes. J Cell Biochem 60: 211–217.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.